Correlation Between Blueprint Medicines and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Travere Therapeutics, you can compare the effects of market volatilities on Blueprint Medicines and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Travere Therapeutics.
Diversification Opportunities for Blueprint Medicines and Travere Therapeutics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Blueprint and Travere is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Travere Therapeutics
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 4.6 times less return on investment than Travere Therapeutics. But when comparing it to its historical volatility, Blueprint Medicines Corp is 1.59 times less risky than Travere Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 1,456 in Travere Therapeutics on August 25, 2024 and sell it today you would earn a total of 369.00 from holding Travere Therapeutics or generate 25.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Travere Therapeutics
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Travere Therapeutics |
Blueprint Medicines and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Travere Therapeutics
The main advantage of trading using opposite Blueprint Medicines and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
| Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. HCW Biologics | Travere Therapeutics vs. Scpharmaceuticals | Travere Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |